SMITH BRIAN TRAVIS 4

What Happened
Brian Travis Smith, an Executive Vice President at Eastman Chemical Co., received equity awards on February 24, 2026: a grant of 53,157 derivative option awards and 7,313 restricted stock units (RSUs), for a total of 60,470 derivative share awards. Both awards are reported at a $0.00 acquisition price in the Form 4 (i.e., they were granted, not purchased or sold), so no cash changed hands at grant.

Key Details

• Transaction date: February 24, 2026; Form filed February 26, 2026 (timely filing).
• Awards: 53,157 derivative option awards; 7,313 restricted stock units (RSUs); total 60,470. Reported price: $0.00 (award/grant).
• Vesting/Exercisability: Options vest in thirds — one‑third exercisable on Feb 24 of 2027, 2028 and 2029 (footnote F1). Each RSU is a contingent right to one share and will vest/payout in unrestricted common shares on Feb 24, 2029 subject to continued employment (footnotes F2, F3).
• Shares owned after transaction: Not provided in the filing.
• Filing timeliness: Filed within the expected reporting window (not marked late).

Context
These are grant awards (not open‑market purchases or sales). Options give the holder the right to buy shares according to the vesting/exercise schedule; RSUs convert to shares only after vesting and payout (here, a 3‑year cliff for the RSUs). Grants are routine executive compensation and do not by themselves indicate whether the insider will buy or sell shares in the market later.